Literature DB >> 17828562

Acute Marchiafava-Bignami disease with callosal, cortical, and white matter involvement.

Lojana Tuntiyatorn1, Jiraporn Laothamatas.   

Abstract

Marchiafava-Bignami disease (MBD) is a rare complication of chronic alcoholism whose main pathology is symmetrical demyelination and necrosis of the corpus callous. The lesion may be found in hemispheric white matter, but the cortical involvement is extremely rare. We reported herein two cases of MBD with magnetic resonance (MR) findings, additional MR spectroscopy, and MR perfusion which revealed acute demyelination at the corpus callosum and symmetrical signal abnormality at cortical gray matter and hemispheric white matter.

Entities:  

Mesh:

Year:  2007        PMID: 17828562     DOI: 10.1007/s10140-007-0640-y

Source DB:  PubMed          Journal:  Emerg Radiol        ISSN: 1070-3004


  5 in total

1.  Marchiafava-Bignami disease: longitudinal MR imaging and MR spectroscopy study.

Authors:  Anna Gambini; Andrea Falini; Lucia Moiola; Giancarlo Comi; Giuseppe Scotti
Journal:  AJNR Am J Neuroradiol       Date:  2003-02       Impact factor: 3.825

2.  Acute Marchiafava-Bignami disease: MR findings in two patients.

Authors:  Andres Arbelaez; Adriana Pajon; Mauricio Castillo
Journal:  AJNR Am J Neuroradiol       Date:  2003 Nov-Dec       Impact factor: 3.825

Review 3.  Clinicoradiologic subtypes of Marchiafava-Bignami disease.

Authors:  Alexander Heinrich; Uwe Runge; Alexander V Khaw
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

4.  Cortical involvement in Marchiafava-Bignami disease.

Authors:  Ken Johkura; Makoto Naito; Takayuki Naka
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

5.  Regional cerebral glucose metabolism and blood flow in a patient with Marchiafava-Bignami disease.

Authors:  K Ishii; Y Ikerjiri; M Sasaki; H Kitagaki; E Mori
Journal:  AJNR Am J Neuroradiol       Date:  1999-08       Impact factor: 3.825

  5 in total
  9 in total

1.  Bilateral middle cerebellar peduncles involvement a malnourished man with Marchiafava-Bignami disease.

Authors:  Yaoyao Shen; Zhijuan Cheng; Tingmin Dai; Hongbing Nie
Journal:  Neurol Sci       Date:  2018-10-18       Impact factor: 3.307

Review 2.  Diagnosis and management of Marchiafava-Bignami disease: a review of CT/MRI confirmed cases.

Authors:  Matti Hillbom; Pertti Saloheimo; Shinsuke Fujioka; Zbigniew K Wszolek; Seppo Juvela; Maurizio A Leone
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-08-26       Impact factor: 10.154

3.  Magnetic resonance spectroscopy and gadolinium enhancement assist in the diagnosis of nonalcoholic Marchiafava-Bignami disease with necrosis lesions: a case description.

Authors:  Zhiwei Zhou; Qinghui Li; Chengyu Pan; Tao Liang; Tijiang Zhang; Ping Xu
Journal:  Quant Imaging Med Surg       Date:  2022-02

4.  Marchiafava-Bignami disease with rare etiology: A case report.

Authors:  Yongjian Cui; Lei Zheng; Xiaoli Wang; Weiwen Zhang; Dongcai Yuan; Yan Wei
Journal:  Exp Ther Med       Date:  2015-02-05       Impact factor: 2.447

5.  Clinical and neuroradiological features of 15 patients diagnosed with Marchiafava-Bignami disease.

Authors:  Yao-Yao Shen; Chen-Guang Zhou; Ning Han; Xin-Ming Liang; You-Qing Deng
Journal:  Chin Med J (Engl)       Date:  2019-08-05       Impact factor: 2.628

6.  Intermediate Syndrome and Marchiafava-Bignami Syndrome: Double Trouble in Weaning Off.

Authors:  Ruchita Kabra; Maharshi Patel; Pratik J Bhansali; Sunil Kumar; Sourya Acharya
Journal:  Cureus       Date:  2022-07-09

7.  Marchiafava-Bignami disease with asymmetric extracallosal lesions.

Authors:  Lei Yang; Wei Qin; Ji-Hua Xu; Wen-Li Hu
Journal:  Arch Med Sci       Date:  2015-08-11       Impact factor: 3.318

Review 8.  Alcohol's Effects on the Brain: Neuroimaging Results in Humans and Animal Models.

Authors:  Natalie M Zahr; Adolf Pfefferbaum
Journal:  Alcohol Res       Date:  2017

9.  Clinical and radiological features of Marchiafava-Bignami disease.

Authors:  Xiaoyu Dong; Chaobo Bai; Jianfei Nao
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.